October 2010
Pharmaceutical Representative;Oct2010, Vol. 40 Issue 10, p10
The article presents an update released by the U.S. Food and Drug Administration on the dosing recommendations for Valcyte (valganciclovir), an antiviral drug used for children and adolescents undergoing kidney and heart transplant, to prevent overdose in children with low body weight and body surface area, and low serum creatinine.


Related Articles

  • FDA Drug Safety Communication: New dosing recommendations to prevent potential Valcyte (valganciclovir) overdose in pediatric transplant patients.  // Biomedical Market Newsletter;12/20/2010, p98 

    The article reports that the U.S. Food & Drug Administration (FDA) is notifying healthcare professionals of new pediatric dosing recommendations for Valcyte oral tablets and oral solution manufactured by Genentech Inc. This change is being made to prevent potential valganciclovir overdosing in...

  • FDA actions in brief.  // Formulary;Oct2009, Vol. 44 Issue 10, p291 

    The article provides information on various drugs approved by the U.S. Food and Drug Administration (FDA). Levocetirizine was approved for treating perennial allergic rhinitis. Bepotastine besilate ophthalmic solution was approved for treating itching in allergic conjunctivitis. Valganciclovir...

  • Ranbaxy gets approval for Valganciclovir hydrochloride tablets.  // PharmaWatch: Biotechnology;Aug2008, Vol. 7 Issue 8, p9 

    The article reports on the approval given by the U.S. Food and Drug Administration (FDA) for the marketing and production of Ranbaxy Laboratories Ltd.'s Valganciclovir hydrochloride tablets. Ranbaxy Laboratories believes that it has the first-to-file status on the drug, thereby rendering them...

  • Valcyte for CMV in peds.  // MPR - Urologists' Edition;Fall2009/Winter2010, Vol. 6 Issue 2, pA4 

    The article reports on the U.S. Food and Drug Administration (FDA) approval received by Hoffman-La Roche Ltd. for its Valcyte (valganciclovir hydrochloride) drug in 2009. Valcyte has gained approval for the prevention of cytomegalovirus (CMV) disease in pediatric kidney and heart transplant...

  • Prescription ads next on FDA list. Colford, S.W. // Advertising Age;8/26/91, Vol. 62 Issue 35, p32 

    Examines Food & Drug Administration (FDA) plans to tighten regulations on drug advertising and various promotional practices. Principal concerns of Commissioner David Kessler; Present regulations of consumer ads for prescription drugs.

  • Over-the-counter drugs. Sommi Jr., R.W. // Current Health 2;May92, Vol. 18 Issue 9, p21 

    Discusses the differences between prescription and nonprescription drugs (also called over-the-counter, or OTC, drugs). Role of the US Food and Drug Administration (FDA); OTC drugs for self-limiting illnesses such as the common cold; The FDA's concern about side effects, clear instructions and...

  • The FDA safeguarding. Kowalski, Kathiann M. // Current Health 2;Jan1996, Vol. 22 Issue 5, p20 

    Presents the work and duties of the Food and Drug Administration (FDA) in the United States. Origin of the agency; Rules followed on food standard inspection; Presence of food chemicals; Safety programs of FDA; Actions of the agency in the presence of problems; Nutrition labeling and Education...

  • Product testing.  // Current Health 1;May92, Vol. 15 Issue 9, p22 

    Discusses the medicine and product testing conducted by the US Food and Drug Administration (FDA). Pharmaceutical tests; How the FDA studies test results; FDA approval; Drug testing in other countries; Tests on food, cosmetics, pesticides; The FDA's concern about food labels; Testing donated blood.

  • Dateline Washington.  // Consumers' Research Magazine;Feb1993, Vol. 76 Issue 2, p6 

    Reports that in January a US District Court judge ruled that the Food and Drug Administration (FDA) is not responsible for $210 million worth of losses incurred by Chilean fruit growers when in 1989, the FDA temporarily banned sales of grapes to the United States. Details of the ruling.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics